Equities

Medinet Co Ltd

2370:TYO

Medinet Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)40.00
  • Today's Change0.00 / 0.00%
  • Shares traded981.10k
  • 1 Year change-11.11%
  • Beta2.2479
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Sep 30 2024202420232022
ASSETS
Cash And Short Term Investments4,6514,3964,499
Total Receivables, Net228217171
Total Inventory506750
Prepaid expenses534026
Other current assets, total314862
Total current assets5,0134,7694,807
Property, plant & equipment, net423478537
Goodwill, net------
Intangibles, net101113102
Long term investments102212485
Note receivable - long term520560563
Other long term assets(458)(498)(417)
Total assets5,7005,6346,078
LIABILITIES
Accounts payable585546
Accrued expenses777165
Notes payable/short-term debt--00
Current portion long-term debt/capital leases0.781.531.99
Other current liabilities, total133219166
Total current liabilities269347279
Total long term debt--0.782.31
Total debt0.782.314.30
Deferred income tax3665128
Minority interest------
Other liabilities, total204177156
Total liabilities509590566
SHAREHOLDERS EQUITY
Common stock6,4865,7375,892
Additional paid-in capital1,3275781,361
Retained earnings (accumulated deficit)(2715)(1418)(2094)
Treasury stock - common0.000.000.00
Unrealized gain (loss)92147353
Other equity, total0.000--
Total equity5,1915,0445,512
Total liabilities & shareholders' equity5,7005,6346,078
Total common shares outstanding265232212
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.